Variables that affect assays for plasma cytokines and soluble activation markers

Clinical and Diagnostic Laboratory Immunology

Volumn 6, Issue 1, 1999, Pages 89-95

  Aziz, Najib ^a   Nishanian, Parunag ^a   Mitsuyasu, Ronald ^b   Detels, Roger ^c   Fahey, John L ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR; NEOPTERIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; DIAGNOSTIC VALUE; DRUG QUALITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INTERMETHOD COMPARISON; LABORATORY DIAGNOSIS; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE DIAGNOSIS;

EID: 0032946346     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.6.1.89-95.1999     Document Type: Article

References (58)

1. Aderka, D., H. Engelmann, Y. Maor, C. Brakebusch, and D. Wallach. 1992. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J. Exp. Med. 175:323-329.
2. Aggarwal, B. B., and R. K. Puri. 1995. Common and uncommon features of cytokines and cytokine receptors: an overview, p. 3-24. In B. B. Aggarwal and R. K. Puri (ed.), Human cytokines: their role in disease and therapy. Blackwell Scientific, Cambridge, Mass.
3. Aukrust, P., N. B. Liabakk, F. Müller, E. Lien, T. Espevik, and S. S. Froland. 1994. Serum levels of tumor necrosis factor-alpha (TNF-α) and soluble TNF receptors in human immunodeficiency virus type 1 infection: correlations to clinical immunologic and virologic parameters. J. Infect. Dis. 169:420-424.
4. Aziz, N., P. Nishanian, and J. L. Fahey. 1998. Levels of cytokines and immune activation markers in plasma in human immunodeficiency virus infection: quality control procedures. Clin. Diagn. Lab. Immunol. 5:755-761.
5. Bienvenu, J., L. Coulon, C. Doche, M. C. Gutowski, and G. Grau. 1993. Analytical performances of commercial ELISA kits for IL-2, IL-6 and TNFα. A WHO study. Eur. Cytokine Netw. 4:447-451.
6. 2-macroglobulin as a cytokine binding plasma protein. J. Biol. Chem. 264:5818-5825.
7. Cannon, J. G., J. L. Nerad, D. D. Poutsiaka, and C. A. Dinarello. 1993. Measuring circulating cytokines. J. Appl. Physiol. 75:1897-1902.
8. Choi, S., S. W. Lagakos, R. T. Schooley, and P. A. Volberding. 1993. CD4 lymphocytes are an incomplete surrogate marker for clinical progression in persons with asymptomatic HIV infection taking zidovudine. Ann. Intern. Med. 118:674-680.
9. De Kossodo, S., V. Houba, G. E. Grau, and the WHO Collaborative Study Group. 1995. Assaying tumor necrosis factor concentrations in human serum. A WHO international collaborative study. J. Immunol. Methods 182: 107-114.
10. Dinarello, C. A. 1992. ELISA kits based on monoclonal antibodies do not measure total IL-1β synthesis. J. Immunol. Methods 148:255-259.
11. Duff, G. W. 1993. Cytokines and anti-cytokines. Br. J. Rheumatol. 32:15-20.
12. Engelberts, I., A. Moller, G. J. M. Schoen, C. J. V. D. Linden, and W. A. Buurman. 1991. Evaluation of measurement of human TNF in plasma by ELISA. Lymphokine Cytokine Res. 10:69-76.
13. Engelberts, I., S. Stephens, G. J. M. Francot, C. J. Van Der Linden, and W. A. Buurman. 1991. Evidence for different effects of soluble TNF receptors on various TNF measurements in human biological fluids. Lancet 338: 515-516.
14. Exley, A. R., and J. Cohen. 1990. Optimal collection of blood samples for the measurement of tumor necrosis factor-alpha. Cytokine 2:353-356.
15. Fahey, J. L. 1998. Cytokines, plasma immune activation markers, and clinically relevant surrogate markers in human immunodeficiency virus infection. Clin. Diagn. Lab. Immunol. 5:597-603.
16. Fahey, J. L., J. M. G. Taylor, R. Detels, B. Hoffmann, R. Melmed, P. Nishanian, and J. V. Giorgi. 1990. The prognostic value of cellular and serological markers in infection with human immunodeficiency virus type 1. N. Engl. J. Med. 322:166-172.
17. Fahey, J. L., J. M. G. Taylor, B. Manna, P. Nishanian, N. Aziz, J. V. Giorgi, and R. Detels. 1998. Prognostic significance of plasma markers of immune activation, HIV viral load and CD4 T-cell measurements. AIDS 12:1581-1590.
18. Fauci, A. S. 1996. Host factors and the pathogenesis of HIV-induced disease. Nature 384:529-534.
19. Fuchs, D., H. Jager, M. Popescu, G. Reibnegger, E. R. Werner, M. P. Dierich, W. Kaboth, G. P. TiIz, and H. Wachter. 1990. Immune activation markers to predict AIDS and survival in HIV-1 seropositives. Immunol. Lett. 26:75-80.
20. Gaines-Das, R. E., and S. Poole. 1993. The international standard for interleukin-6 - evaluation in an international collaborative study. J. Immunol. Methods 160:147-153.
21. Gearing, A. J. H., J. E. Cartwright, and M. Wadhwa. 1991. Biological and immunological assays for cytokines, p. 339-355. In A. Thomson (ed.), The cytokine handbook. Academic Press Ltd., London, United Kingdom.
22. Giorgi, J. V., H.-L. Cheng, J. B. Margolick, K. D. Bauer, J. Ferbas, M. Waxdel, I. Schmid, L. E. Hultin, A. L. Jackson, L. Park, L. M. Taylor, and the Multicenter AIDS Cohort Study Group. 1990. Quality control in the flow cytometric measurement of T-lymphocyte subsets: the multicenter AIDS cohort study experience. Clin. Immunol. Immunopathol. 55:173-186.
23. Hansen, M. B., M. Svenson, M. Diamant, and K. Bendizen. 1993. High affinity IgG autoantibodies to IL-6 in sera of normal individuals are competitive inhibitors of IL-6 in vitro. Cytokine 5:72-80.
24. Hofmann, B., H. Bass, P. Nishanian, M. Faisal, R. A. Figlin, G. P. Sarna, and J. L. Fahey. 1992. Different lymphoid cell populations produce varied levels of neopterin, β2-microglobulin and soluble IL-2 receptor when stimulated with IL-2, interferon-gamma or tumor necrosis factor-alpha. Clin. Exp. Immunol. 88:548-554.
25. Hofmann, B., Y. X. Wang, W. C. Cumberland, R. Detels, M. Bozorgmehri, and J. L. Fahey. 1990. Serum β2-microglobulin level increases in HIV-1 infection: relation to seroconversion, CD4 T cell fall and prognosis. AIDS 4:207-214.
26. Huber, C., J. R. Batchelor, D. Fuchs, A. Hausen, A. Lang, D. Niederwieser, G. Reibnegger, P. Swetly, J. Troppmair, and H. Wachter. 1984. Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma. J. Exp. Med. 160:310-316.
27. 2-macroglobulin in commercial cytokine assays. J. Immunol. Methods 168: 33-37.
28. Kapadia, S., G. Torre-Amione, and D. L. Mann. 1994. Pitfalls in measuring cytokines. Ann. Intern. Med. 121:149-150.
29. Ledur, A., C. Fitting, B. David, C. Hamberger, and J.-M. Cavaillon. 1995. Variable estimates of cytokine levels produced by commercial ELISA kits improved results using international cytokine standards. J. Immunol. Methods 186:171-179.
30. Leroux-Roels, G., F. Offner, J. Philippe, and A. Vermeulen. 1988. Influence of blood collecting systems on concentrations of tumor necrosis factor in serum and plasma. Clin. Chem. 34:2373-2374.
31. Mae, N., D. J. Liberato, R. Chizzonite, and H. Satoh. 1991. Identification of high-affinity anti-IL-1α autoantibodies in normal human serum as an interfering substance in a sensitive enzyme-linked immunosorbent assay for IL-1α. Lymphokine Cytokine Res. 10:61-68.
32. 2-macroglobulin as a carrier protein for IL-6. J. Immunol. 142:148-152.
33. Meager, A., H. Leung, and J. Wooley. 1989. Assays for tumor necrosis factor and related cytokines. J. Immunol. Methods 116:1-17.
34. Mellors, J. W., C. R. Rinaldo, P. Gupta, R. M. White, J. A. Todd, and L. A. Kingsley. 1996. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272:1167-1170.
35. Mellors, J. W., A. Munoz, J. V. Giorgi, J. B. Margolick, C. J. Tassoni, P. Gupta, L. A. Kingsley, J. A. Todd, A. J. Saah, R. Detels, J. P. Phair, and C. R. Rinaldo, Jr. 1997. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann. Intern. Med. 126:946-954.
36. Melmed, R. N., J. M. G. Taylor, R. Detels, M. Bozorgmehri, and J. L. Fahey. 1989. Serum neopterin changes in HIV-1 infected subjects: indicator of significant pathology, CD4 T cell changes, and the development of AIDS. J. Acquired Immune Defic. Syndr. 2:70-76.
37. Mire-Sluis, A. R. 1993. Cytokines - protein structure and biological activity: a complex relationship with implication for biological assays and standardization. Biologicals 21:131-144.
38. Mire-Sluis, A. R., R. Gaines-Das, and R. Thorpe. 1995. Immunoassays for detecting cytokines: what are they really measuring? J. Immunol. Methods 186:157-160.
39. Mire-Sluis, A. R., R. Gaines-Das, R. Thorpe, and Participants of the Collaborative Study. 1995. The international standard for granulocyte-macrophage colony stimulating factor (GM-CSF) - evaluation in an international collaborative study. J. Immunol. Methods 179:127-135.
40. Mire-Sluis, A. R., R. Gaines-Das, R. Thorpe, and Participants of the Collaborative Study. 1995. The international standard for macrophage colony stimulating factor (M-CSF) - evaluation in an international collaborative study. J. Immunol. Methods 179:141-151.
41. Mire-Sluis, A. R., R. Gaines-Das, R. Thorpe, and Participants of the Collaborative Study. 1997. Implications for the assay and biological activity of interleukin-8. J. Immunol. Methods 200:1-16.
42. Osmund, D. H., S. Shiboski, P. Bacchetti, E. E. Winger, and A. R. Moss. 1991. Immune activation markers and AIDS prognosis. AIDS 5:505-511.
43. Pesce, A. J., and J. G. Michael. 1992. Artifacts and limitations of enzyme immunoassays. J. Immunol. Methods 150:111-119.
44. Petyovka, N., L. Lyach, and N. N. Voitenok. 1995. Homologous ELISA for detection of oligomeric human TNF: properties of assay. J. Immunol. Methods 186:161-170.
45. Plaeger, S., H. Z. Bass, P. Nishanian, J. Thomas, N. Aziz, R. Detels, J. King, W. Cumberland, M. Kemeny, and J. L. Fahey. The prognostic significance in HIV infection of immune activation represented by cell surface antigen and plasma activation marker changes. Clin. Immunol. Immunopathol., in press.
46. Poli, G., and A. S. Fauci. 1995. Role of cytokines in the pathogenesis of human immunodeficiency virus infection, p. 421-450. In B. B. Aggarwal and R. K. Puri (ed.), Human cytokines: their role in disease and therapy. Blackwell Scientific, Cambridge, Mass.
47. Poole, S., and R. E. Gaines-Das. 1991. The international standards for IL-1α and IL-1ß - evaluation in an international collaborative study. J. Immunol. Methods 142:1-13.
48. Riches, P., R. Gooding, B. C. Millar, and A. W. Rowbottom. 1992. Influence of collection and separation of blood samples on plasma IL-1, IL-6 and TNF-α concentrations. J. Immunol. Methods 153:125-131.
49. H2 cytokine in HIV infection. Immunol. Rev. 140:73-92.
50. Roux-Lombard, P., G. Steiner, and the Cytokine Consensus Study Group of the European Workshop for Rheumatology Research. 1992. Preliminary report on cytokine determination in human synovial fluids: a consensus study of the European Workshop for Rheumatology Research. Clin. Exp. Rheumatol. 10:515-520.
51. Rubin, L. A., C. C. Kurman, M. E. Fitz, and B. Boutin. 1985. Soluble interleukin-2 receptors are released from activated human lymphoid cells in vitro. J. Immunol. 135:3172-3177.
52. Seckinger, P., J. H. Zhang, B. Hauptmann, and J. M. Dayer. 1990. Characterization of a tumor necrosis factor-α inhibitor: evidence of immunological cross-reactivity with the TNF receptor. Proc. Natl. Acad. Sci. USA 87:5188-5192.
53. 2-macroglobulin. Prog. Leukoc. Biol. 8:209-212.
54. Thavasu, P. W., S. Longhurst, S. P. Joel, M. L. Slevin, and F. R. Balkwill. 1992. Measuring cytokine levels in blood: importance of anticoagulants, processing and storage conditions. J. Immunol. Methods 153:115-124.
55. Thorpe, R., M. Wadhwa, C. R. Bird, and A. R. Mire-Sluis. 1992. Detection and measurement of cytokines. Blood Rev. 6:133-148.
56. Tsoukas, C. M., and N. F. Bernard. 1994. Markers predicting progression of human immunodeficiency virus-related disease. Clin. Microbiol. Rev. 7:14-28.
57. Van Kessel, K. P. M., J. A. G. Van Strijp, and J. Verhoeff. 1991. Inactivation of recombinant human tumor necrosis factor-α by proteolytic enzymes released from stimulated human neutrophils. J. Immunol. 147:3862-3868.
58. Whicher, J., and E. Ingham. 1990. Cytokine measurements in body fluids. Eur. Cytokine Netw. 1:239-243.